Literature DB >> 15173162

Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis.

Harry R Davis1, Li-Ji Zhu, Lizbeth M Hoos, Glen Tetzloff, Maureen Maguire, Jianjun Liu, Xiaorui Yao, Sai Prasad N Iyer, My-Hanh Lam, Erik G Lund, Patricia A Detmers, Michael P Graziano, Scott W Altmann.   

Abstract

Niemann-Pick C1 Like 1 (NPC1L1) is a protein localized in jejunal enterocytes that is critical for intestinal cholesterol absorption. The uptake of intestinal phytosterols and cholesterol into absorptive enterocytes in the intestine is not fully defined on a molecular level, and the role of NPC1L1 in maintaining whole body cholesterol homeostasis is not known. NPC1L1 null mice had substantially reduced intestinal uptake of cholesterol and sitosterol, with dramatically reduced plasma phytosterol levels. The NPC1L1 null mice were completely resistant to diet-induced hypercholesterolemia, with plasma lipoprotein and hepatic cholesterol profiles similar to those of wild type mice treated with the cholesterol absorption inhibitor ezetimibe. Cholesterol/cholate feeding resulted in down-regulation of intestinal NPC1L1 mRNA expression in wild type mice. NPC1L1 deficiency resulted in up-regulation of intestinal hydroxymethylglutaryl-CoA synthase mRNA and an increase in intestinal cholesterol synthesis, down-regulation of ABCA1 mRNA, and no change in ABCG5 and ABCG8 mRNA expression. NPC1L1 is required for intestinal uptake of both cholesterol and phytosterols and plays a major role in cholesterol homeostasis. Thus, NPC1L1 may be a useful drug target for the treatment of hypercholesterolemia and sitosterolemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173162     DOI: 10.1074/jbc.M405817200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  184 in total

1.  Use of NBD-cholesterol to identify a minor but NPC1L1-independent cholesterol absorption pathway in mouse intestine.

Authors:  Michelle R Adams; Eddy Konaniah; James G Cash; David Y Hui
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-11       Impact factor: 4.052

2.  Multiple mechanisms limit the accumulation of unesterified cholesterol in the small intestine of mice deficient in both ACAT2 and ABCA1.

Authors:  Stephen D Turley; Mark A Valasek; Joyce J Repa; John M Dietschy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

3.  Opposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8).

Authors:  J Mark Brown; Liqing Yu
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2009-03

4.  Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake.

Authors:  Liang Ge; Wei Qi; Li-Juan Wang; Hong-Hua Miao; Yu-Xiu Qu; Bo-Liang Li; Bao-Liang Song
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

5.  Ezetimibe is an inhibitor of tumor angiogenesis.

Authors:  Keith R Solomon; Kristine Pelton; Kelly Boucher; Jinsoo Joo; Christopher Tully; David Zurakowski; Carl P Schaffner; Jayoung Kim; Michael R Freeman
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

6.  Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.

Authors:  Ryan E Temel; Weiqing Tang; Yinyan Ma; Lawrence L Rudel; Mark C Willingham; Yiannis A Ioannou; Joanna P Davies; Lisa-Mari Nilsson; Liqing Yu
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

7.  Distinct Cation Gradients Power Cholesterol Transport at Different Key Points in the Hedgehog Signaling Pathway.

Authors:  Kostadin Petrov; Bradley M Wierbowski; Jingjing Liu; Adrian Salic
Journal:  Dev Cell       Date:  2020-08-28       Impact factor: 12.270

8.  Ezetimibe impairs uptake of dietary cholesterol oxidation products and reduces alterations in hepatic cholesterol metabolism and antioxidant function in rats.

Authors:  Shoichiro Terunuma; Noriko Kumata; Kyoichi Osada
Journal:  Lipids       Date:  2013-04-16       Impact factor: 1.880

9.  Diosgenin stimulation of fecal cholesterol excretion in mice is not NPC1L1 dependent.

Authors:  Ryan E Temel; J Mark Brown; Yinyan Ma; Weiqing Tang; Lawrence L Rudel; Yiannis A Ioannou; Joanna P Davies; Liqing Yu
Journal:  J Lipid Res       Date:  2009-01-13       Impact factor: 5.922

10.  Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine.

Authors:  Yajun Cheng; Fuli Liu; Jun Wu; Yao Zhang; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2009-09-24       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.